These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30686825)

  • 1. The many faces of tumor necrosis factor signaling in the intestinal epithelium.
    Delgado ME; Brunner T
    Genes Immun; 2019 Nov; 20(8):609-626. PubMed ID: 30686825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic functions of TNF-α in the regulation of the intestinal epithelial response to inflammation.
    Leppkes M; Roulis M; Neurath MF; Kollias G; Becker C
    Int Immunol; 2014 Sep; 26(9):509-15. PubMed ID: 24821262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-10 blocked endoplasmic reticulum stress in intestinal epithelial cells: impact on chronic inflammation.
    Shkoda A; Ruiz PA; Daniel H; Kim SC; Rogler G; Sartor RB; Haller D
    Gastroenterology; 2007 Jan; 132(1):190-207. PubMed ID: 17241871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial TNF Receptor Signaling Promotes Mucosal Repair in Inflammatory Bowel Disease.
    Bradford EM; Ryu SH; Singh AP; Lee G; Goretsky T; Sinh P; Williams DB; Cloud AL; Gounaris E; Patel V; Lamping OF; Lynch EB; Moyer MP; De Plaen IG; Shealy DJ; Yang GY; Barrett TA
    J Immunol; 2017 Sep; 199(5):1886-1897. PubMed ID: 28747340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.
    Breese EJ; Michie CA; Nicholls SW; Murch SH; Williams CB; Domizio P; Walker-Smith JA; MacDonald TT
    Gastroenterology; 1994 Jun; 106(6):1455-66. PubMed ID: 8194690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
    Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
    J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of muscarinic receptors prevents TNF-α-mediated intestinal epithelial barrier disruption through p38 MAPK.
    Uwada J; Yazawa T; Islam MT; Khan MRI; Krug SM; Fromm M; Karaki SI; Suzuki Y; Kuwahara A; Yoshiki H; Sada K; Muramatsu I; Taniguchi T
    Cell Signal; 2017 Jul; 35():188-196. PubMed ID: 28412413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mediators of immunity and inflammation in inflammatory bowel disease.
    Monteleone G; Fina D; Caruso R; Pallone F
    Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice.
    Fukumoto K; Naito Y; Takagi T; Yamada S; Horie R; Inoue K; Harusato A; Hirata I; Omatsu T; Mizushima K; Hirai Y; Yoshida N; Uchiyama K; Ishikawa T; Handa O; Konishi H; Wakabayashi N; Yagi N; Kokura S; Ichikawa H; Kita M; Yoshikawa T
    Int J Mol Med; 2011 Mar; 27(3):353-9. PubMed ID: 21249312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.
    Kontoyiannis D; Boulougouris G; Manoloukos M; Armaka M; Apostolaki M; Pizarro T; Kotlyarov A; Forster I; Flavell R; Gaestel M; Tsichlis P; Cominelli F; Kollias G
    J Exp Med; 2002 Dec; 196(12):1563-74. PubMed ID: 12486099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
    Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
    Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Glutamyl cysteine and γ-glutamyl valine inhibit TNF-α signaling in intestinal epithelial cells and reduce inflammation in a mouse model of colitis via allosteric activation of the calcium-sensing receptor.
    Zhang H; Kovacs-Nolan J; Kodera T; Eto Y; Mine Y
    Biochim Biophys Acta; 2015 May; 1852(5):792-804. PubMed ID: 25558818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell death at the intestinal epithelial front line.
    Delgado ME; Grabinger T; Brunner T
    FEBS J; 2016 Jul; 283(14):2701-19. PubMed ID: 26499289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin D is Upregulated by Synergy of Notch Signalling and TNF-α in the Inflamed Intestinal Epithelia of IBD Patients.
    Kawamoto A; Nagata S; Anzai S; Takahashi J; Kawai M; Hama M; Nogawa D; Yamamoto K; Kuno R; Suzuki K; Shimizu H; Hiraguri Y; Yui S; Oshima S; Tsuchiya K; Nakamura T; Ohtsuka K; Kitagawa M; Okamoto R; Watanabe M
    J Crohns Colitis; 2019 Mar; 13(4):495-509. PubMed ID: 30395194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.
    Atreya R; Zimmer M; Bartsch B; Waldner MJ; Atreya I; Neumann H; Hildner K; Hoffman A; Kiesslich R; Rink AD; Rau TT; Rose-John S; Kessler H; Schmidt J; Neurath MF
    Gastroenterology; 2011 Dec; 141(6):2026-38. PubMed ID: 21875498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.
    Noguchi M; Hiwatashi N; Liu Z; Toyota T
    Gut; 1998 Aug; 43(2):203-9. PubMed ID: 10189845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.